Identification of an Iridium(III)-Based Inhibitor of Tumor Necrosis Factor-α-Reference-Cited by-同舟云学术

Identification of an Iridium(III)-Based Inhibitor of Tumor Necrosis Factor-α

Published:2016-04-14 Issue:8 Volume:59 Page:4026-4031
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Kang Tian-Shu¹,Mao Zhifeng²,Ng Chan-Tat¹,Wang Modi²,Wang Wanhe²,Wang Chunming¹,Lee Simon Ming-Yuen¹,Wang Yitao¹,Leung Chung-Hang¹,Ma Dik-Lung²

Affiliation:

1. State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Taipa, Macao, P. R. China

2. Department of Chemistry, Hong Kong Baptist University, Kowloon Tong, Hong Kong, P. R. China

Funder

Agence Nationale de la Recherche

Universidade de Macau

Health and Medical Research Fund

Research Grants Council, University Grants Committee, Hong Kong

Hong Kong Baptist University

Fundo para o Desenvolvimento das Ciências e da Tecnologia

Shum Yiu Foon Sum Bik Chuen Memorial Centre for Cancer and Inflammation Research, Hong Kong Baptist University

State Key Laboratory of Environmental and Biological Analysis, Hong Kong Baptist University

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.6b00112

Reference46 articles.

1. The potential of organometallic complexes in medicinal chemistry

2. Metal complexes as potential modulators of inflammatory and autoimmune responses

3. An Iridium(III) Complex Inhibits JMJD2 Activities and Acts as a Potential Epigenetic Modulator

4. Group 9 Organometallic Compounds for Therapeutic and Bioanalytical Applications

5. Activation of C–H Bonds in Nitrones Leads to Iridium Hydrides with Antitumor Activity

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Iridium(III) complexes as novel theranostic small molecules for medical diagnostics, precise imaging at a single cell level and targeted anticancer therapy;European Journal of Medicinal Chemistry;2024-10

2. Organometallic d6, d8 and d10 metal complexes for biosensing and imaging, cancer therapy and theranosis;Journal of Organometallic Chemistry;2024-02

3. Study on the Multimodal Anticancer Mechanism of Ru(II)/Ir(III) Complexes Bearing a Poly(ADP-ribose) Polymerase 1 Inhibitor;Journal of Medicinal Chemistry;2023-10-03

4. Prediction of Cancer Treatment Using Advancements in Machine Learning;Recent Patents on Anti-Cancer Drug Discovery;2023-08

5. Mitochondria-targeted cyclometalated iridium-β-carboline complexes as potent non-small cell lung cancer therapeutic agents;Metallomics;2023-05-18